Overview

Asia-Pacific IVF Services Market is poised to value over USD 12.7 billion by 2027 end at a CAGR of over 12.2% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Asia-Pacific IVF Services Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Asia-Pacific IVF Services Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Asia-Pacific IVF Services Market:
• Apollo Hospitals Dhaka
• Australian Concept Infertility Medical Center (ACIMC)
• Bahosi Fertility Centre
• Bangkok IVF center
• Bloom Fertility and Healthcare
• Bloom Fertility Center
• Bourn Hall Fertility Center
• Bumrungrad International Hospital
• Center for Advanced Reproductive Medicine and Infertility
• CHA Fertility Center
• Chennai Fertility Center
• Cloudnine Fertility
• Damai Service Hospital
• Fatemieh Infertility Center
• Fertility Associates
• Fertility Centre Nepal (Part of Wecare Health Services, India)
• Fertility First
• Flinders Reproductive Medicine Pty Ltd
• Genea Oxford Fertility Limited
• IHH Healthcare Berhad
• IVF NAMBA Clinic
(Note: The list of the major players will be updated with the latest market scenario and trends)

Asia-Pacific IVF Services Market Segmentation:
By Cycle Type
• Fresh IVF Cycles (Non-Donor)
• Thawed IVF Cycles (Non-Donor)
• Donor Egg IVF Cycles

By End User
• Fertility Clinics
• Hospitals
• Surgical centers
• Clinical research institutes

By Region
• Japan
• China
• India
• Australia and New Zealand
• ASEAN
• Rest of Asia Pacific

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Asia-Pacific IVF Services Market By Cycle Type, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— Japan, China, India, Australia and New Zealand, ASEAN, Rest of Asia Pacific.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Asia-Pacific IVF Services Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Asia-Pacific IVF Services Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Asia-Pacific IVF Services Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Asia-Pacific IVF Services Market, By Cycle Type Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Fresh IVF Cycles (Non-Donor)
  7.2. Thawed IVF Cycles (Non-Donor)
  7.3. Donor Egg IVF Cycles

8. Asia-Pacific IVF Services Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
  8.1. Fertility Clinics
  8.2. Hospitals
  8.3. Surgical centers
  8.4. Clinical research institutes

9. Asia Pacific Asia-Pacific IVF Services Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   9.1. Introduction
   9.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         9.2.1. Japan
         9.2.2. China
         9.2.3. India
         9.2.4. Australia and New Zealand
         9.2.5. ASEAN
         9.2.6. Rest of Asia Pacific
   9.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027  

10. Market Share Analysis and Competitive Landscape  
   10.1. Asia Pacific Landscape - Key Players, Revenue and Presence
   10.2. Asia Pacific Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   10.3. Asia Pacific Emerging Companies
   10.4. Asia Pacific - Market Share Analysis and Key Regional Players
   10.5. Asia Pacific Key Player - Growth Matrix

11. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   11.1. Apollo Hospitals Dhaka
         11.1.1. Company Overview
         11.1.2. Product Portfolio
         11.1.3. SWOT Analysis
         11.1.4. Financial Overview
         11.1.5. Strategic Overview
   11.2. Australian Concept Infertility Medical Center (ACIMC)
         11.2.1. Company Overview
         11.2.2. Product Portfolio
         11.2.3. SWOT Analysis
         11.2.4. Financial Overview
         11.2.5. Strategic Overview
   11.3. Bahosi Fertility Centre
         11.3.1. Company Overview
         11.3.2. Product Portfolio
         11.3.3. SWOT Analysis
         11.3.4. Financial Overview
         11.3.5. Strategic Overview
   11.4. Bangkok IVF center
         11.4.1. Company Overview
         11.4.2. Product Portfolio
         11.4.3. SWOT Analysis
         11.4.4. Financial Overview
         11.4.5. Strategic Overview
   11.5. Bloom Fertility and Healthcare
         11.5.1. Company Overview
         11.5.2. Product Portfolio
         11.5.3. SWOT Analysis
         11.5.4. Financial Overview
         11.5.5. Strategic Overview          
   11.6. Bloom Fertility Center
         11.6.1. Company Overview
         11.6.2. Product Portfolio
         11.6.3. SWOT Analysis
         11.6.4. Financial Overview
         11.6.5. Strategic Overview      
   11.7. Bourn Hall Fertility Center
         11.7.1. Company Overview
         11.7.2. Product Portfolio
         11.7.3. SWOT Analysis
         11.7.4. Financial Overview
         11.7.5. Strategic Overview
   11.8. Bumrungrad International Hospital
         11.8.1. Company Overview
         11.8.2. Product Portfolio
         11.8.3. SWOT Analysis
         11.8.4. Financial Overview
         11.8.5. Strategic Overview
   11.9. Center for Advanced Reproductive Medicine and Infertility
         11.9.1. Company Overview
         11.9.2. Product Portfolio
         11.9.3. SWOT Analysis
         11.9.4. Financial Overview
         11.9.5. Strategic Overview
   11.10.CHA Fertility Center
         11.10.1. Company Overview
         11.10.2. Product Portfolio
         11.10.3. SWOT Analysis
         11.10.4. Financial Overview
         11.10.5. Strategic Overview
   11.11.Chennai Fertility Center
         11.11.1. Company Overview
         11.11.2. Product Portfolio
         11.11.3. SWOT Analysis
         11.11.4. Financial Overview
         11.11.5. Strategic Overview
   11.12.Cloudnine Fertility
         11.12.1. Company Overview
         11.12.2. Product Portfolio
         11.12.3. SWOT Analysis
         11.12.4. Financial Overview
         11.12.5. Strategic Overview
   11.13.Damai Service Hospital
         11.13.1. Company Overview
         11.13.2. Product Portfolio
         11.13.3. SWOT Analysis
         11.13.4. Financial Overview
         11.13.5. Strategic Overview
   11.14.Fatemieh Infertility Center
         11.14.1. Company Overview
         11.14.2. Product Portfolio
         11.14.3. SWOT Analysis
         11.14.4. Financial Overview
         11.14.5. Strategic Overview
   11.15.Fertility Associates
         11.15.1. Company Overview
         11.15.2. Product Portfolio
         11.15.3. SWOT Analysis
         11.15.4. Financial Overview
         11.15.5. Strategic Overview
   11.16.Fertility Centre Nepal (Part of Wecare Health Services, India)
         11.16.1. Company Overview
         11.16.2. Product Portfolio
         11.16.3. SWOT Analysis
         11.16.4. Financial Overview
         11.16.5. Strategic Overview
   11.17.Fertility First
         11.17.1. Company Overview
         11.17.2. Product Portfolio
         11.17.3. SWOT Analysis
         11.17.4. Financial Overview
         11.17.5. Strategic Overview
   11.18.Flinders Reproductive Medicine Pty Ltd
         11.18.1. Company Overview
         11.18.2. Product Portfolio
         11.18.3. SWOT Analysis
         11.18.4. Financial Overview
         11.18.5. Strategic Overview
   11.19.Genea Oxford Fertility Limited
         11.19.1. Company Overview
         11.19.2. Product Portfolio
         11.19.3. SWOT Analysis
         11.19.4. Financial Overview
         11.19.5. Strategic Overview
   11.20.IHH Healthcare Berhad
         11.20.1. Company Overview
         11.20.2. Product Portfolio
         11.20.3. SWOT Analysis
         11.20.4. Financial Overview
         11.20.5. Strategic Overview
   11.21.IVF NAMBA Clinic
         11.21.1. Company Overview
         11.21.2. Product Portfolio
         11.21.3. SWOT Analysis
         11.21.4. Financial Overview
         11.21.5. Strategic Overview

12. Pre and Post COVID-19 Impact
   12.1. Positive influence on the healthcare industry
   12.2. The financial disruption of the manufacturing sector
   12.3. Impact of COVID-19 on emerging companies
   12.4. Significant mandates in the healthcare regulations initiated by administrations
   12.5. The overall economic slowdown of the developing and developed nations

13. FutureWise SME Key Takeaway Points for Client

Tables

Figures